Evidence map›Paper›PMID 35216024›Full record

ArticleViruses2022

Vaccinia Virus Arrests and Shifts the Cell Cycle.

Caroline K Martin, Jerzy Samolej, Annabel T Olson, Cosetta Bertoli, Matthew S Wiebe, Robertus A M de Bruin, Jason Mercer

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Caroline K MartinMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.
Jerzy SamolejInstitute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0003-0615-3297
Annabel T OlsonSchool of Biological Sciences, University of Nebraska, Lincoln, NE 68583, USA.
Cosetta BertoliMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.
Matthew S WiebeSchool of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583, USA.ORCID 0000-0001-6337-6556
Robertus A M de BruinMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.ORCID 0000-0001-9957-1409
Jason MercerInstitute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.
MRC Laboratory for Molecular Cell Biology · GBUniversity of Birmingham · GBUniversity of Nebraska–Lincoln · US

Funding

Mechanism of the Antiviral Activity of BAF Against Poxvirus and HSV-1 InfectionR01AI114653 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI WIEBE, MATTHEW S · 2015 to 2019
$1.8M
Engagement of Cellular Mitotic and Antiviral Signaling by Poxviral KinasesR56AI153099 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI WIEBE, MATTHEW S · 2021 to 2021
$426k
Cancer Research UK 20147Medical Research Council MC_UU_00012/7NIAID NIH HHS R01 AI114653NIAID NIH HHS R56 AI153099
6 · The paper itself

Abstract

Modulation of the host cell cycle is a common strategy used by viruses to create a pro-replicative environment. To facilitate viral genome replication, vaccinia virus (VACV) has been reported to alter cell cycle regulation and trigger the host cell DNA damage response. However, the cellular factors and viral effectors that mediate these changes remain unknown. Here, we set out to investigate the effect of VACV infection on cell proliferation and host cell cycle progression. Using a subset of VACV mutants, we characterise the stage of infection required for inhibition of cell proliferation and define the viral effectors required to dysregulate the host cell cycle. Consistent with previous studies, we show that VACV inhibits and subsequently shifts the host cell cycle. We demonstrate that these two phenomena are independent of one another, with viral early genes being responsible for cell cycle inhibition, and post-replicative viral gene(s) responsible for the cell cycle shift. Extending previous findings, we show that the viral kinase F10 is required to activate the DNA damage checkpoint and that the viral B1 kinase and/or B12 pseudokinase mediate degradation of checkpoint effectors p53 and p21 during infection. We conclude that VACV modulates host cell proliferation and host cell cycle progression through temporal expression of multiple VACV effector proteins. (209/200.).

Indexed as

DNA DamageCell CycleCell ProliferationHCT116 CellsHeLa CellsHost-Pathogen InteractionsHumansMutationTumor Suppressor Protein p53Vaccinia virusViral ProteinsVirus ReplicationTumor Suppressor Protein p53Viral Proteinscell cycleDNA damage responsekinasep53vaccinia virus

Identifiers

PMID35216024
PMCPMC8874441
OpenAlexW4213008845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.